Shearman & Sterling represented Caris Life Sciences Inc. in the transaction. Caris Life Sciences Inc. executed an $830 million growth equity round. As a result of...
Shearman & Sterling represented Caris Life Sciences Inc. in the transaction. Caris Life Sciences Inc. executed an $830 million growth equity round. As a result of...
You must be a Standard 1 Year member to access this content.